Health
25 Oct 2019 Nemesis Bio: using CRISPR-Cas9 to tackle antibiotic resistance
Frank Massam, PhD and Professor Conrad Lichtenstein, PhD are co-founders of Nemesis Bioscience. This biopharmaceutical company is developing...
Insights
All posts tagged "deephealth"